Adams State Trustee Scoggin will address fall graduates

(12-02-2013)

charles scoggin

Charles H. Scoggin, M.D. is the Adams State University Fall 2013 Commencement Speaker. The ceremony begins at 10 a.m., Saturday, Dec. 14, in Plachy Hall. Adams State will award 145 degrees, including 107 bachelor's degrees, and 38 associate degrees.

Scoggin has founded and led several biomedical businesses. He is currently, chairman, president and chief executive officer of Sagemed, Inc., a Boulder, Colorado-based company focused on creating awareness and understanding of new and innovative health care products and services. He is a board member, and vice-chair, of the Center of the American West, and has a particular interest in issues of health and the American West. He also serves as a trustee for Adams State University.

He received his medical degree from the University of Colorado, training in internal medicine at Duke University and pulmonary medicine and critical care in the Division of Pulmonary Sciences at the University of Colorado, and training in molecular and cellular biology at the University of Colorado and Eleanor Roosevelt Institute.

He has held the positions of professor of medicine at the University of Colorado, clinical director of the Department of Medicine of the University of Colorado, director of the House Staff Training Program of the Department of Medicine at the University of Colorado, head of the Adult Human Genetics Section of the University of Colorado and senior scientist and vice-president of the Eleanor Roosevelt Institute. During his academic career, Dr. Scoggin received numerous awards and recognitions. He was Teaching and Research Scholar of the American College of Physicians, a Fellow of the American College of Physicians, Research Scholar of the American Lung Association, and Fellow of the American College of Chest Physicians.

In addition to Sagemed, companies which Scoggin has founded or co-founded include: Somatogen, a biopharmaceutical company that successfully synthesized and genetically modified the human hemoglobin molecule. Scoggin served as president, CEO and chairman through Somatogen's initial public offering, and several secondary financings and strategic alliances; Somatogen Instruments, a biomedical and scientific instruments company. He served as president and CEO until the sale of the company to Beckman Instruments; Rodeer Systems, a biomedical informatics company.

He has authored over 150 scientific articles, book chapters, and abstracts. Scoggin and his wife, Karen Louise Scoggin, have two children.

Steve Valdez, chair of the Adams State Board of Trustees, will convey the greetings from the board, while Chelsea Oden will deliver the 2013 class message. Dr. Christine Keitges, professor of music, will lead the singing of the Alma Mater. A reception will follow the ceremony for graduates and their guests in the Plachy Hall Field House.